Grove EL - Search Results

1

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.

Würtz M, Grove EL. Würtz M, et al. Among authors: grove el. Curr Pharm Des. 2012;18(33):5344-61. doi: 10.2174/138161212803251925. Curr Pharm Des. 2012. PMID: 22724409 Review.

2

Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.

Nielsen HL, Kristensen SD, Thygesen SS, Mortensen J, Pedersen SB, Grove EL, Hvas AM. Nielsen HL, et al. Among authors: grove el. Thromb Res. 2008;123(2):267-73. doi: 10.1016/j.thromres.2008.03.023. Epub 2008 May 21. Thromb Res. 2008. PMID: 18499236

3

Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.

Hedegaard SS, Hvas AM, Grove EL, Refsgaard J, Rocca B, Daví G, Kristensen SD. Hedegaard SS, et al. Among authors: grove el. Thromb Res. 2009 May;124(1):96-100. doi: 10.1016/j.thromres.2008.12.034. Epub 2009 Feb 11. Thromb Res. 2009. PMID: 19215971

4

Update on oral antiplatelet therapy: principles, problems and promises.

Grove EL, Kristensen SD. Grove EL, et al. Future Cardiol. 2009 May;5(3):247-58. doi: 10.2217/fca.09.10. Future Cardiol. 2009. PMID: 19450051 Review.

5

Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy.

Grove EL, Hvas AM, Kristensen SD. Grove EL, et al. Kardiol Pol. 2008 Apr;66(4):478-9. Kardiol Pol. 2008. PMID: 19496276 No abstract available.

6

Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.

Pedersen SB, Grove EL, Nielsen HL, Mortensen J, Kristensen SD, Hvas AM. Pedersen SB, et al. Among authors: grove el. Platelets. 2009 Sep;20(6):415-20. doi: 10.1080/09537100903100643. Platelets. 2009. PMID: 19658002 Free article.

7

The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.

Würtz M, Grove EL, Kristensen SD, Hvas AM. Würtz M, et al. Among authors: grove el. Heart. 2010 Mar;96(5):368-71. doi: 10.1136/hrt.2009.181107. Epub 2009 Nov 11. Heart. 2010. PMID: 19910291 Free article.

8

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.

Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM. Mortensen SB, et al. Among authors: grove el. Thromb Res. 2010 Oct;126(4):e318-22. doi: 10.1016/j.thromres.2010.03.013. Epub 2010 May 7. Thromb Res. 2010. PMID: 20451957

9

Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.

Würtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD. Würtz M, et al. Among authors: grove el. JACC Cardiovasc Interv. 2010 Aug;3(8):828-35. doi: 10.1016/j.jcin.2010.05.014. JACC Cardiovasc Interv. 2010. PMID: 20723855 Free article.

10

Increased platelet turnover in patients with previous definite stent thrombosis.

Grove EL, Würtz M, Hvas AM, Kristensen SD. Grove EL, et al. J Thromb Haemost. 2011 Jul;9(7):1418-9. doi: 10.1111/j.1538-7836.2011.04304.x. J Thromb Haemost. 2011. PMID: 21501377 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters